trump rx glp 1 President announced the popular GLP-1 weight loss drugs would soon be more accessible to millions of Americans at a cost of only $50 per month Medicare is about to cover

doi: 10.1016/j.biopha.2018.12.104 551 untarIPetricZBursa KovaeviDPutnikP

Emerging evidence demonstrates that GLP-1 receptor agonists may provide significant benefits for liver health, particularly in patients with metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as non-alcoholic fatty liver disease or NAFLD) and its inflammatory subtype, metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH)

A lot of these people dont need to be on these medicines. This article first appeared in The Checkup, MIT Technology Reviews weekly biotech newsletter

One study found that CoQ-10 supplementation increased sperm concentration by up to 80%